Skip to main navigation
  • Home
    • Company
    • Need for Abuse Deterrent Products
    • Platforms
  • Technologies
    • Technology Platforms
    • AVERSION®
    • IMPEDE®
    • LIMITX™
  • Market Opportunity
    • Market Opportunity
    • Partnerships
    • Advocacy Groups
    • Patents
    • Business Development
  • Product Portfolio
    • Product Pipeline
    • OXAYDO®
    • NEXAFED® Product Line
    • LIMITX™ Products in Development
    • Important Safety Info
  • Clinical
    • Medical Meeting Calendar
  • Investors

    Investors

    • Investors
    • Press Releases
    • News & Events
    • Corporate Governance
      • Management
      • Directors
      • Committees
      • ContactBoard
    • Financial Information
      • SEC Filings
      • Quarterly Results
      • Key Ratios
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Ownership Profile
    • Risk Factors
    • Contact Us
 

acura

Contact Us
 
Share this on: Close window
delicious Delicious
Digg Digg
Facebook Facebook
LinkedIn LinkedIn
Twitter Twitter

Investor Relations

  • Investors
  • Press Releases
  • News & Events
  • Corporate Governance
  • Financial Information
  • Stock Information
  • Risk Factors
  • Contact Us

Shareholder Tools

  • Email Alerts
  • Downloads
  • RSS News
  • Print Page
  • Share This

Press Releases

Company News
Summary Toggle Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave
Apr 25, 2011

Read more

Summary ToggleAcura Pharmaceuticals Reports Year-End And Fourth Quarter 2010 Financial Results And Product Development Update
Mar 01, 2011

Read more

Summary ToggleACUROX® Tablets New Drug Application Accepted For Filing With A Priority Review Classification
Feb 14, 2011

Read more

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 6
  • Page 7
  • Page 8
  • Current page 9
Displaying 145 - 147 of 147 results

Copyright © 1998-2020 Acura Pharmaceuticals. All rights reserved. Terms of Use and Privacy Policy Risk Factors Contact Us